By Josh Beckerman

Biocept Inc. shares rose 72% to 61 cents following the company's announcement late Thursday that it will conduct Covid-19 testing.

Biocept, which provides liquid biopsy tests for cancer patients, said it would begin accepting physician-ordered Covid-19 testing requests for processing April 15.

Biocept's lab will use Thermo Fisher Scientific Inc.'s TaqPath platform and kit.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

April 13, 2020 13:05 ET (17:05 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Thermo Fisher Scientific Charts.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Thermo Fisher Scientific Charts.